Hormonal modulation of reproduction-specific thiamin carrier protein in the rat by Malathy, P. V. & Adiga, P. R.
J. Biosci., Vol. 7, Number 2, March 1985, pp. 77–94. © Printed in India. 
 
 
 
 
Hormonal modulation of reproduction–specific thiamin carrier
protein in the rat
 
 
P. V. MALATHY and P. R. ADIGA 
ICMR Center for Advanced Study in Reproductive Biology, Department of Biochemistry,
Indian Institute of Science, Bangalore 560 012, India 
 
MS received 14 December 1984 
 
Abstract. The hormonal modulation of thiamin carrier protein in the plasma and uterine
luminal secretion during the normal reproductive phases of the animal (estrous cycle and
pregnancy) as well as during experimental estrogenisation was investigated in the rat using a
specific and sensitive homologous radioimmunoassay procedure developed for this purpose.
Following a single injection of estrogen to immature male rats, thiamin carrier protein rapidly
accumulated in plasma attaining peak concentration at 48 h and declining thereafter. A 1·5-
fold amplification of the inductive response was observed on secondary stimulation with the
hormone. The magnitude of the response exhibited a clear dependency on the dose of the
steroid hormone, whereas the time at which peak levels of thiamin carrier protein production
was remained unaltered in the concentration range of the steroid tested. The inductive effect of
estrogen was severely curtailed by the antiestrogens, viz., En- and Zu-clomiphene citrates,
while progesterone was incapable of either modulating the estrogen-induced response or
eliciting an induction by itself. Cycloheximide drastically blocked the response to estrogen.
Evidence for the ability of uterus to serve as yet another independent site of thiamin carrier
protein synthesis was obtained by in vitro incorporation of radioactive amino acids into
immunoprecipitable thiamin carrier protein in the tissue explants of estrogenised female rats.
The levels of thiamin carrier protein in uterine luminal fluid measured during estrous cycle,
pregnancy and experimental estrogenisation exhibited remarkable similarity to the plasma
thiamin carrier protein profiles. 
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Introduction
 
Earlier investigations in this laboratory (Adiga and Murty 1983) have revealed that
estradiol-17β (E2) administration to immature chicks can elicit de novo biosynthesis of 
riboflavin carrier protein (RCP) and thiamin carrier protein (TCP); the kinetics of these
inductive responses exhibit an overall similarity to those governing the hormonally-
induced elaboration of vitellogenin (Gruber et al., 1976; Tata and Smith, 1979; Tata,
1970). With regard to RCP, evidence has been recently adduced for a dual site of
biogenesis, viz., the estrogenised liver and the oviduct in the birds, which respond to the
same hormonal signal to elaborate the vitamin carrier, but with certain subtle
 
 
Abbreviations used: E2, Estradiol 17ß; RCP, riboflavin carrier protein; TCP, thiamine carrier protein; RIA,
radioimmunoassay; AH; aminohexyl; PBS, sodium phosphate buffer, pH 7·2 containing 0·9 % NaCl; BSA,
bovine  serum  albumin;  PMSF,  phenylmethylsulphonyl  fluoride;  IgG,  immunoglobulin  G.
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differences in terms of kinetic details and hormonal specificity during subsequent
hormonal stimulations (Durga Kumari, 1985). With the discovery for the first time of
the evolutionary conservation of RCP in terms of structure and function in mammals
(Adiga and Murty, 1983), recent researches have shown that in the female rat RCP
levels fluctuate in consonance with changing levels of E2 during estrous cycle and
pregnancy (Muniyappa and Adiga, 1980a) and that administration of E2 can induce de
novo this specific protein in male rats with kinetic patterns closely resembling those
encountered in birds (Murty and Adiga, 1982). These findings suggest the possibility
that other similarly conserved gene products might have retained certain basic aspects
of their hormonal inducibility and responsiveness in the mammalian liver in addition to
their  structural  and  functional  characteristics. 
We have recently (Adiga and Muniyappa, 1978) reported on the occurrence as well as
isolation and physicochemical characterisation of TCP from the pregnant rat for the
first time (Malathy, 1985). Since preliminary data revealed that this specific vitamin
carrier can also be detected immunologically in E2-treated rodent sera, it was of interest
to estimate the amount of this protein by developing a specific and sensitive
homologous radioimmunoassay (RIA) so that the details of its physiological modu-
lation and endocrine basis could be examined.
The data presented in this paper clearly establish E2 as the primary endocrine signal
responsible for TCP induction in the rodent liver. In addition, they reveal that the
hormone stimulated uterus is an additional site of biosynthesis of this vitamin carrier.
 
Materials  and methods
 
Thirty five-day-old male and 21-day old female rats (Wistar) from our Institute Colony
were fed on a pelleted diet (Hindustan Lever Products, Bombay) and water ad libitum
and exposed to a 14–10 h light-dark schedule. TCP was purified from pregnant or
estrogenised rat sera by affinity chromatography on TPP-aminohexyl-(AH)-Sepharose
(Malathy, 1985). The antiserum against the purified rat TCP was raised in rabbits by
subcutaneous injections of the protein (100 µg) emulsified with Freund's complete
adjuvant, once a week, for 3 weeks followed by a booster dose of the protein (100 µg) in
saline. A week after the booster injection, venous blood was collected from the ear,
serum separated and kept frozen at – 20°C. Na125I for iodination of the protein was
purchased from the Radiochemical Center, Amersham, Buckinghamshire, UK. [14C]-
Labelled Chlorella hydrolysate was procured from Bhaba Atomic Research Centre,
Bombay and served as a source of [14C] -amino acids. The sources of other chemicals
and reagents were the same as described earlier (Muniyappa and Adiga, 1980b).
Hormones and antiestrogens in propane-1, 2-diol were administered intramuscularly,
whereas cycloheximide in 0·01 Μ sodium phosphate buffer, pH 7·2 /0·15 Μ NaCl was
injected intraperitoneally. Blood samples were collected by cardiac puncture and
uterine secretions were collected by flushing the uteri with 0·01 Μ sodium phosphate
buffer,  pH  7·2/0·15 Μ  NaCl.
 
Homologous radioimmunoassay for thiamin carrier protein 
 The iodination of TCP was performed at room temperature in the presence of iodogen
(Fraker and Speck, 1978). Briefly, 5 µg of TCP in 50 µl of 0·1 Μ sodium phosphate
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buffer, pH 7·5 was introduced into an iodogen coated tube and exposed to 0·25 mCi of
carrier-free Na125I for 1 min. The iodinated protein was resolved from free iodine by
gel filtration chromatography on a Sephacryl S-200 column (1·5 cm × 42 cm) pre-
equilibrated with sodium phosphate, 0·01 Μ pH 7·2 containing 0·9 % NaCl (PBS)
containing 0·2 % (w/v) bovine serum albumin (BSA). The presence of BSA ensured
complete recovery of the protein from the column. Aliquots (100 µl) from each fraction
(0·5 ml) were counted for radioactivity in a mini gamma counter (LKB-Model 1275).
The  iodinated  protein  was  stored  frozen  in  small  batches. 
 
Immunoassay procedure 
 
It may be mentioned that the isolated rat TCP even when iodinated using the relatively
milder iodogen method, resolved by gelfiltration on Sephacryl-200 into fractions of
both higher and lower molecular sizes presumably representing aggregation and
fragmentation respectively. These fractions were able to bind to the antiserum non-
specifically. Therefore, only those labelled protein fractions which exhibited the
specific binding to the antiserum i.e., displaceable by a 100-fold excess uniodinated
protein, were pooled and used for RIA. An antiserum dilution
capable of binding 25–30% of the labelled protein was selected. The assay was
performed at 37°C (Moudgal and Madhwaraj, 1974). The diluted antiserum (0·1 ml)
was incubated with 0·5-1000 ng of rat TCP for the standard in duplicates and 10–25 µl
of 1:100 diluted plasma samples and 10–50 µl of uterine flushings with appropriate
controls (samples from untreated animals) for 10–12 h. Labelled protein (Ca
25,000 cpm) was added to all the tubes and incubation was continued for another 12 h
and the antigen-antibody complex was precipitated by the double antibody method
(Murthy and Adiga, 1978) in the presence of a carrier (0·1 ml of 1:100 diluted normal
rabbit serum). The bound radioactivity in the immunoprecipitates was determined
after centrifugation at 5000 g in a Sorval RC 5B centrifuge for 15 min. The amounts of
TCP in the unknown samples were calculated by extrapolation from the standard curve
(figure 1) that was constructed by adding various known amounts of the unlabelled
 
 
 
Figure 1. Standard curve for the radioimmunoassay for rat thiamin carrier protein. The
dilution  of  the  antiserum  used  was  1:10000.  Details  in  the text. 
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protein to the antiserum. The total bound radioactivity in the protein refers to the
amount of specifically bound radioactivity in the absence of the unlabelled protein. The
non-specific binding (to non-immunised rabbit serum) was 3–8 % of the total input
radio activity  and  this  was always subtracted. 
 
Interassay  and  intrassay  variations 
 
Aliquots from a single pool of serum sample were analysed 4–8 times for interassay and
intraassay variations and the data were analysed statistically (Mulholland and Jones,
1968). Coefficients of intra and inter assay variations were 3–6 % and the assay method
had  a  sensitivity  of  1 ng.
 
Determination of  half-life  of  TCP
 
Freshly [125I]-labelled TCP (~5×105 cpm) was injected to estrogenised and
untreated immature male rats and day 14 pregnant rats. The labelled protein was
diluted with unlabelled purified rat TCP (100 µg) when administered to the control or
untreated animals. Blood samples withdrawn at suitable intervals were counted for
radioactivity and subsequently treated with antiserum to rat TCP (1:1000) for 6 h at
37°C to ensure that the blood radioactivity represented that due to injected TCP. A
least  square  fit  of  the  data  was computed. 
 
In vitro incorporation of [14C]-amino acids into uterine tissue explants 
 
The uterine tissue slices (150–200 mg) from estrogen-primed (5mg/kg body wt.) and
untreated (control) rats were transferred quickly into 25 ml conical flasks containing 2
ml of Krebs-Ringer bicarbonate buffer, pH 7·4. 5 µCi of [14C]-labelled chlorella
hydrolysate was added to each flask, flushed with oxygen for 20 sec, tightly corked and
incubated at 37°C with shaking in a water bath for 4 h. The incubation was terminated
by placing the flasks in ice for 5 min. A homogenate (10% w/v) of the tissue along with
the incubation medium was prepared in 25 mM Tris-HCl (pH 7·6) containing 25 mM
NaCl, 5mM MgCl2, 1% Triton X-100 and 0·1 mM phenylmethylsulphonyl fluoride
(PMSF) with a motor-driven glass-teflon homogeniser. The homogenate was centri-
fuged at 105,000 g for 60 min in a Spinco L5-ultracentrifuge and the supernatant stored
at – 20°C was used for the immunoprecipitation of labelled TCP employing excess of
rat TCP antiserum. The amount of radioactivity incorporated into 10 % trichloroacetic
acid-insoluble proteins was determined by placing on Whatman No. 3 filter paper discs,
50 µl aliquots of uterine cytosols prepared from control and estrogenised immature rats
(Palmiter, 1972). To determine the radioactivity specifically associated with TCP,
0·5ml aliquots of [l4C]-labelled cytosol preparations were incubated with 100 µl of rat
TCP antiserum in the presence of rat cold TCP (10 µg) as a carrier. Following
immunoprecipitation 10 µg of rat cold TCP was added to the clarified supernatants and
incubated with 100 µl of the TCP antiserum. Radioactivity in these immunoprecipi-
tates was taken to represent non-specific radioactivity. The immunoprecipitates
obtained were electrophoresed on 10% Polyacrylamide gels under both reducing and
non-reducing conditions (Weber and Osborn, 1968).At the end of the run ,the gels were
stained to locate the protein bands on the gel. The gels were then sliced into pieces of
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0·5 cm dimensions, digested with 30% H2O2 and counted in toluene: 2-methoxy
ethanol (1:1, v/v) containing 0·5% 2,5-diphenyl oxazole (w/v) by liquid scintillation
spectrometry. 
 
Results 
 
Physiological modulation of circulatory levels of TCP 
 
Following the detection of TCP-like protein with cross-reactivity to the chicken
vitamin carrier in sera of rats during gestation (Adiga and Muniyappa, 1978), the
modulation of this specific protein in the rodent sera during estrous cycle and different
stages of pregnancy were investigated (figure 2) using the sensitive and specific
 
 
 
Figure 2. Plasma levels of thiamin carrier protein during pregnancy. The values represent
mean  and  vertical  bars  represent  S.D.  (n =  5).
 
 
homologous RIA (figure 1). During gestation, a significant amount of TCP could be
measured as early as day 4 of pregnancy i.e., even before implantation, suggesting that
the protein is of maternal origin (figure 2). The concentration of TCP progressively
increased to reach peak values on day 13 and thereafter steadily declined to base-line
values (i.e., of day 1) by day 16 to maintain a steady state level thereafter. It is
noteworthy that high concentrations of the protein in circulation were encountered
between days 11 to 14 which coincide with the critical period of rapid embryonic growth
and organogenesis (Guha and Janne, 1976). Levels of TCP in serum more or less
correlated with the reported estrogen levels (Shaikh, 1971) upto day 14 of pregnancy,
but not later on. In regularly cycling rats with a 4-day estrous cycle, a good parallelism
between serum concentrations of the steroid hormone (Shaikh, 1971) and TCP levels
was clearly evident, with the proestrous estrogen surge coinciding with peak
concentration of TCP (figure 3). This pattern of TCP modulation by estrogen in cycling
rats was analogous to that observed with RCP during the estrous cycle (Muniyappa
and  Adiga, 1980a). 
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Figure 3. Plasma levels of thiamin carrier protein during estrous cycle. The values represent
mean and vertical bars represent S.D. (n = 5). PE, Proestrous; E, estrous; DE-I, diestrous I;
DE-II, diestrous  II  of the  cycle.
 
 
Induction of thiamin carrier protein in male rats
 
Since preliminary observations suggested that the sera from estrogen-treated male rats
exhibited a clear-cut immunological cross-reactivity with antiserum to purified chicken
and rat TCPs, the time-course of accumulation of this protein following estrogenis-
ation was investigated. Figure 4 depicts the kinetics of induction and disappearance of
TCP during both primary and secondary stimulation with the steroid (10 mg/kg body
 
 
Figure 4. Time course of accumulation of thiamin carrier protein in the plasma after
sequential injections (EI, EII) of estradiol- 17β in propane- 1, 2-diol (10 mg/kg body wt:). The
values  represent  mean  and  vertical  bars  represent  S.D . (n = 5).
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wt.) in 35-day old male rats. The plasma TCP levels measured prior to estrogen dosing
represent base-line values which varied from 0·25–2·5 µg/ml depending on the batch of
animals and/or feed. Significant increments in TCP levels were observed in the rat as
early as 6 h following a single estrogen dose. Thereafter, the level increased gradually
with time reaching peak values of approximately 50 µg/ml by about 48 h. This was
followed by a steady decline and by 15 days, the levels returned to the base-line values.
Two weeks after steroid withdrawal when the same animals were again challenged
with a second but same dose of E2, the circulating TCP levels exhibited a similar kinetic
pattern  except  that  the  response  was  amplified  roughly  1·5-fold. 
 
Hormonal dose-dependency of TCP elaboration during primary stimulation 
 
The effect of varying E2 doses during primary stimulation on the rates of accumulation
and disappearance of TCP is depicted in figure 5. It is evident that a hormonal dose as
low as 0·1 mg/kg body wt. (<10 µg/rat) elicited a measurable response which
progressively increased with the steroid dose. However, the time taken to reach the
maximal levels remained unaltered within the ranges of E2 dose tested (0·1 to 10 mg/kg
body wt.). The rates of accumulation as well as the peak levels reached exhibited a dose-
dependent phenomenon. Interestingly, however, the rates of clearance of protein
 
 
 
Figure 5. Hormonal dose-dependent response of plasma thiamin carrier protein during
primary stimulation. Time course of plasma TCP accumulation with increasing concentra-
tions  of  estradiol-17ß  (mg/kg body wt.).  (▲) ,  0·1; (∆), 1; (●) , 5; (○), 10. 
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during the decay phase decreased with increasing E2 dosage, i.e., the protein required
longer  periods  to  reach  the  base-line  value. 
 
Rate of disappearance of TCP
 
The kinetics of disappearance of injected [125I]-labelled TCP from the circulation
of control, E2-treated 35-day old male rats and day 14-pregnant rats (figure 6)
revealed that the exogenously administered TCP disappeared from circulation
in a biphasic manner with an initial rapid phase (A) presumably representing
 
 
Figure 6. Rate of disappearance of  [125I]-labelled thiamin carrier protein from the plasma.
Freshly prepared [125I]-labelled TCP (Ca. 5 × 105 cpm) was injected into estrogenised or
untreated immature male rats or day 14 pregnant rats and at the indicated time intervals blood
samples were collected and the plasma prepared were monitored for radioactivity. The values
represent mean and the vertical bars represent S.D. (n = 5). A, Phase of rapid disappearance; B,
phase of catabolism.
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dilution of the label with extravascular space and tissue binding followed
by a slower phase (B) of disappearance, representing metabolic clearance
(McFarlane, 1964). The disappearance during the catabolic phase followed first
order kinetics and a least square fit of the data in control, estrogenised and
pregnant rats yielded half-lives of 4·5, 8 and 5·5 h respectively. These values obtained
from direct measurement of plasma radioactivity could be confirmed by im-
munoprecipitation of [125I]-labelled TCP in these samples which uniformly cor-
responded to 80% of the total blood radioactivity. The half-life of TCP following
estrogenisation was doubled and this ‘stabilising’ effect of estrogen, on the protein
might account for the relatively lower clearance rates of TCP from circulation
following higher steroid dosing (figure 5). During gestation, the half-life of TCP was
between the half-life in untreated and estrogen-treated rats. This marginal difference in
the catabolic rates in control versus pregnant animals could be due to the interplay of
several  hormones  during  gestation.
 
Influence of cycloheximide
 
To rule out the possibility that the rapid TCP accumulation in the plasma after
hormone administration merely reflected an interference with the altered metabolic
clearance rate, especially at lower hormonal doses, evidence for de novo synthesis of the
specific protein was sought by administering cycloheximide, a powerful translation
inhibitor. When this drug was administered intraperitoneally (0·8 mg/kg body wt.)
30 min prior to steroid administration, a drastic decrease in TCP levels was observed
when measured at 48 h, i.e., at a time when maximal concentration of TCP was
otherwise encountered (table 1). It was evident that induction of the specific protein
above   the  base-line  was  totally  abolished. 
 
Table 1. Effect of the administration of cycloheximide on
estrogen-induced  TCP  accumulation.
 
*  Pre-injection  value. 
Cycloheximide (0·8 mg/kg body wt.) was administered intra-
peritoneally 30 min prior to estradiol-17ß injection and
plasma  TCP  levels  estimated  at  48 h  after  estrogenisation. 
Data are expressed as mean ± S.D. (n = 4). 
 
 
Effect of progesterone and antiestrogens
 
Progesterone administration did not have any measurable influence on the kinetics of
estrogen-induced TCP production in the rodent with regard to the rates of TCP
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accumulation and decay (table 2). In other words, the level of plasma TCP was
unaffected when progesterone was administered in combination with E2 during
primary stimulation. Furthermore, progesterone when administered singly also failed
to  induce  the  protein  above the  base-line value.
 
Table 2. Effect of progesterone on the
estradiol-stimulated  plasma  TCP  content.
 
 
* Pre-injection  value. 
Estradiol-17ß + progesterone (10 mg of 
each/kg body wt.) or progesterone
(10mg/kg body wt.) were administered
intramuscularly and plasma TCP levels
estimated at 48 h after the treatment. Data 
are expressed as mean ± S.D. (n = 4).
 
The absolute hormonal specificity of induction of TCP could also be shown by
exposing the animals to potent synthetic antiestrogens, viz., En- and Zu-clomiphene
citrates, 30 min prior to E2 treatment. Both the antiestrogens severely curtailed the
estrogenic response of TCP and were effective by themselves to elicit only weak
estrogen-like  activity  with  regard  to  TCP  production (table 3).
 
Table 3. Influence of antiestrogens on the estradiol-stimulated plasma TCP content. 
 
 
En-and Zu-clomiphene citrates (100 mg/kg body wt.) were administered 30 min prior to estradiol-
17ß administration and plasma TCP was estimated at 48 h after estrogenisation. Data are
expressed  as  mean  ±  S.D.  (n = 4). 
 
 
Uterine expression of TCP and hormonal modulation
 
The presence of TCP in the uterine flushings of immature rats primed with E2 was
detected by using the homologous RIA. While the uterine luminal fluid from
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estrogenised rats was able to compete with [125I]-labelled TCP for binding to its
antiserum in a dose-dependent manner, the corresponding samples from control
animals failed to show such competition (figure 7). It would therefore appear that E2
was capable of inducing uterine synthesis besides hepatic modulation. It is also
possible that TCP in the uterine flushings may have been released from the serum into
the uterine lumen by a transudative process due to increased capillary permeability
brought about  E2  (Daniel,  1971).
 
 
Figure 7. Displacement of [125I]-labelled thiamin carrier protein from its homologous
antiserum by uterine flushings. The dilution of the specific anti-serum used was 1:10,000.
Details  in  the  text,  (○),  Rat  TCP  standard;  (●), uterine  flushings. 
 
 
Conclusive proof for the de novo synthesis of TCP by the estrogenised rat uterus was
obtained from in vitro experiments with [14C]-labelled amino acids. Both the tissue and
the medium were processed simultaneously to recover both the tissue and secreted
TCP. It is evident from table 4, that on treatment of the cytosol fractions with TCP
antiserum (in the presence of unlabelled TCP as a carrier), about 0·8–1·0% of the total
labelled protein could be immunoprecipitated from the estrogenised rodent uterus
whereas only < 0·04 % of the radioactivity could be recovered from the cytosols of the
control tissue. The identity of this “in vitro synthesised TCP” was confirmed by
subjecting the immunoprecipitate to sodium dodecyl sulphate polyacrylamidegel
electrophoresis (SDS-PAGE) (Weber and Osborn, 1968). Electrophoresis of the
samples both in the presence and in the absence of β-mercaptoethanol was necessary to
rule out the possibility of radioactivity being associated with other protein components,
like Η-chain of IgG which has a molecular weight very similar to that of TCP. The
unambiguous evidence for the elaboration of TCP by the uterus upon E2 stimulation is
presented in figure 8. All the radioactivity in the immunoprecipitate could be located in
the region of.TCP, while no measurable radioactivity was associated with any protein
fraction  on  the  gel  in  the  case  of  control animals. 
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Table 4. In vitro incorporation of [14C]-amino acids into uterine tissue explants. 
 
The total amount of radioactivity associated with TCP precipitable proteins were measured in uterine
cytosols of estrogen-stimulated (5 mg/kg body wt.) and untreated (control) 21-day old female rats.
Radioactivity specifically associated with TCP was estimated by immunoprecipitation of cytosols with
monospecific  rat  TCP  antiserum.
 
 
 
 
Figure  8.  Distribution of radioactivity in the immunoprecipitates by SDS-PAGE. Aliquots
(0·5 ml) of [14C]-labelled uterine cytosol preparations were immunoprecipitated with 0·1 ml
of rat TCP a/s in  the  presence  of  cold  rat  TCP  (10  µg).  Details  in  the  text.
(●), SDS-PAGE of immunoprecipitate in absence of ß-mercaptoethanol; (○), SDS-PAGE in
presence of β-mercaptoethanol; (∆), SDS-PAGE of immunoprecipitate from uterine cytosol of
control animals.
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Hormonal modulation of uterine TCP content
 
Experimental estrogenisation (various doses of E2 in the range 0·1–5·0 mg E2/rat)
resulted in an increase in the concentration of TCP in the uterine flushings (figure 9) in a
manner similar to the dose response observed in the plasma. The content of TCP in the
uterine fluid is expressed per unit protein, since the total volume of uterine fluid could
not be measured. Such a measurement also avoids possible errors arising from changes
in uterine fluid volume following estrogenisation. Beyond a certain concentration of
the steroid, the stimulatory effect observed on tissue weight and TCP concentration
plateaued of, the increase in protein response being no longer proportional to the
steroid dosage. Simultaneous measurement of TCP in both plasma and uterine
flushings revealed qualitatively similar patterns. The uterine contents of TCP show an
absolute specificity for E2 (like hepatic synthesis) since clomiphene citrate ad-
ministrated 30 min prior to E2-dosing, severely inhibited the hormone specific response
(figure 9). Progesterone administered at a dose of 10 mg/kg body wt. was ineffective in
inducing  this  response. 
 
 
Figure  9.  Effect of estrogen on uterine weight and thiamin carrier protein content in the
uterine flushings. 21-day old female rats were administered clomiphene citrate, progesterone
and estradiol-17β at the indicated concentration in propane-l,2-diol (mg/rat). Details in the
text.  The  values  represent  mean  and  vertical  bars  represent  S.D.  (n =  5). 
AE, The antiestrogen clomiphene citrate.
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The modulation of TCP contents in uterine tissue by physiological concentrations of
the hormone was evident from the changing patterns of TCP in the lumen during
estrous cycle and pregnancy. Figure 10 depicts the inductive response of TCP elicited
during 4-day estrous cycle. It is clear that the content of TCP was the highest during
proestrous  phase  when the  concentration  of plasma  estrogen  is maximum.
 
 
 
Figure 10.  Content of thiamin carrier protein in uterine flushings during estrous cycle. The
values  represent  mean  and  vertical  bars  represent  S.D. (n = 4). 
PE,  proestrous;  Ε,  estrous;  DE-I,  diestrous  I;  DE-II,  diestrous  II  of  the cycle.
 
During gestation, the changes of TCP contents in the uterine fluid and the plasma were
similar (figure 2). Significant level of TCP was detectable on day 1 of pregnancy. The
hormonal signal responsible for this early triggering of TCP synthesis could be the
estrogen surge occurring during proestrous phase of the fertile cycle. A similar surge in
estrogen (Shaikh and Abraham, 1969) occurring at the time of implantation, i.e., day 4 of
pregnancy, might have brought an enhanced response as reflected in a further increase
in TCP; thereafter,  the  protein remained  at  more  or less  constant levels (figure  11).
 
 
 
Figure 11. Thiamin carrier protein content in uterine flushings during pregnancy. The
values  represent  mean  and  vertical  bars  represent S.D. (n = 4). 
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Discussion 
 
The first indication that estrogen is the predominant hormonal signal modulating
circulatory TCP levels during the reproductive phase of the rat (estrous cycle and
pregnancy) was the changing pattern of the protein concentration in plasma in concert
with parallel alterations in the steroid levels (figures 2 and 3). This suggestion was
confirmed by the observation that a single injection of the steroid hormone to male rats
acutely induced the vitamin carrier. In analogy with the hormone-induced TCP
biogenesis in the chicken liver (Muniyappa and Adiga, 1980b), the kinetics of TCP
induction in the rodent included a rapid phase of accumulation of the protein in plasma
followed by a declining phase of clearance from circulation during primary stimulation.
Similarly a significant amplification of the response on secondary stimulation was
observed. However, when the details of the inductive responses in the avian and the
rodent species are compared, certain subtle qualitative and quantitative differences
became obvious beneath these overall similarities. For example, the amplification of
response during secondary stimulation in the rat was only marginal (1·5-fold)
compared to that in the chicken system (4–fold). Particularly striking was the absence of
a detectable lag period preceding the marked rise in plasma TCP levels during primary
stimulation in the rodents as in the chicken (4–5 h). Another contrasting feature was the
capacity of the steroid to significantly prolong the circulatory t–2 of TCP in the rat,
unlike in the birds (Muniyappa and Adiga, 1980b). The mechanism underlying these
differences between the two systems may be related to such factors as species-specific
differential organisation and expression of the specific gene concerned and/or the rate
and pattern of metabolic clearance of the steroid from the inductive loci at the
hepatocyte  level.
A similar comparison of the kinetic parameters of E2-induced TCP synthesis with
those governing RCP elaboration in the rodent system (Murty and Adiga, 1982) also
reveal several interesting features of similarity and differences. Particularly contrasting
is the relatively prolonged (24 h) latent period attendent on RCP induction during
primary stimulation. Not withstanding this difference, several gross similarities in the
induction of RCP and TCP in the rodent liver were apparent; these included subsequent
phases of rapid accumulation and decay in circulation and similar orders of
amplification during secondary stimulation. These observations would imply that the
mechanisms underlying the inductive responses of the two vitamin carriers in the
mammalian  and  avian  liver  (Muniyappa  and  Adiga,  1980b)  are  very  similar.
It was unequivocally demonstrated earlier that specific estrogen receptors capable of
rapid nuclear translocation and functional interaction with chromatin acceptor sites
are present in the hepatocytes of both male and female rats (Atew et al., 1978) and
that low doses (50–100 µg/kg body wt.) of the hormone markedly change the
composition and functional facets of the rodent liver (Seal and Doe, 1969). Since within
minutes after hormone administration, E2-receptor complexes attained saturating
concentration in the hepatic nuclei, it is quite likely that TCP induction was triggered
soon thereafter, since a marked elevation in the plasma TCP levels are encountered
within a short-time after E2-dosing. It is most likely that this difference in the kinetics of
induction between TCP and RCP may be related to a greater sensitivity and
responsiveness of TCP gene vis-a-vis that of RCP to the hormone. It was shown earlier
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that different threshold concentrations of E2-receptor complex were needed at the
nuclear chromatin sites to elicit induction of different inducible proteins in the chicken
oviduct (Palmiter et al., 1981). The magnification of response observed during
secondary stimulation, culminating in greater synthetic capability has been traced to a
more pronounced transcription and cytoplasmic stabilisation of the corresponding
mRNAs presumably brought about by permanent changes in chromatin in the
oviparous species (Jost et al., 1978; Weintraub and Groudine, 1976). The data
presented in figure 4 clearly reinforce the earlier finding (Murty and Adiga, 1982) that
the typical 'memory effect' observed during secondary stimulation is not confined
to oviparous species only, but extends to viviporous mammals. The abolute specificity
of E2 for TCP induction was supported by the finding (table 3) that both the isomers of
the antiestrogen completely annulled the inductive response; progesterone alone was
ineffective in this respect and also failed to modulate the estrogen influence on de novo
TCP  synthesis. 
The relevance of these kinetic details and hormonal specificity of TCP induction in
the male rats administered pharmacological doses of the steroid hormone to
physiological situation in the adult females became evident when TCP profiles in the
plasma were examined during estrous cycle and pregnancy. Since physiological
concentrations of the steroid hormone bear a good correlation with the levels of the
vitamin carrier protein, clearly the sex steroid is the primary inducer and modulator of
the protein. The lack of a strict temporal relationship between plasma estrogen and
TCP levels throughout the gestation period, particularly after day 14 might in part be
ascribed to the complexity and multiplicity of hormonal interactions prevalent during
this particular physiological state. As pregnancy progressed there was a steady rise in
TCP content in maternal circulation which attained peak levels around day 13 and
declined sharply thereafter (figure 2). The high levels of TCP in maternal circulation
observed around days 9–14 clearly coincided with the critical period of rapid embryonic
growth attended by marked differentiation and organogenesis (Guha and Janne, 1976).
It is conceivable that the precipitous decline in maternal TCP levels after this stage is a
reflection of accelerated and efficient sequestration of the vitamin-bound TCP by the
fetoplacental unit from the maternal supply line; in other words, a ‘fetal sink’ may be
operating which may be responsible for augmented depletion of the vitamin carrier
from the maternal circulation at rates higher than its synthesis in the maternal liver.
Alternatively, the vitamin carrier may be subject to rapid catabolic clearance from
maternal circulation subsequent to the delivery of the vitamin at the placental site for
use by the rapidly proliferating fetal tissue. Another possibility may be related to
decreased rate of hepatic synthesis consequent to an apparent ‘feed-back’ signal from
the fetal compartment.
The rodent uterus, yet another target organ for estrogen, also serves as an additional
site of TCP elaboration during the reproductive phase of the animal. While a mere
demonstration of the occurrence of TCP in high concentrations in this estrogen-
stimulated reproductive tissue does not confer on it the privilege of a biosynthetic site,
the data of table 4 and figure 8 clearly show that the uterine tissue can indeed synthesise
TCP in vitro as revealed by incorporation of [14C]-labelled amino acids into
immunoprecipitable TCP. That the same hormonal signal influences independently the
de novo synthesis of TCP in this extra hepatic tissue is shown by the pattern of
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stimulation by physiological concentrations of the steroid hormone. However a
significant proportion of TCP in the uterine lumina may originate from the circulation
as a transudate, particularly since the transudation of serum proteins (IgG, albumin,
transferrin) is also dependent on the hormonal status (Daniel, 1971; Wira and Sandoe,
1980). Estrogenic substances are known to influence not only the capillary permeability
but also epithelial cell membrane and their junctional complexes besides affecting the
basal membrane between the stroma and the epithelium thus causing selective
transport of serum proteins (Beier, 1976). It is therefore conceivable that the increase in
uterine luminal TCP content observed during pregnancy/estrous cycle may be
attributed atleast in part to in situ production, although an appreciable proportion of
this  protein  may  be  derived  from the  plasma. 
However, neither the relative contribution of uterine tissue nor the functional
relevance of the presence of TCP in high concentrations in the luminal fluid under
physiological conditions are at present known. It is attractive to visualise that the
localised synthesis of TCP may have some relevance in providing a nutritive milieu in
the immediate vicinity of the implanting embryo. A number of hormone-stimulated
specific proteins, such as Ε-induced uterine protein (IP) in the rat (Mairesse and
Galand, 1982), uteroglobin in the rabbit (Beier, 1974), uteroferrin in the pig (Geisert et
al., 1982) and some normal serum constituents are known to be present in luminal fluid
in appreciable concentrations and some of these proteins are taken up by the blastocyst
for its nutrition by an endocytotic mechanism (Parr and Parr, 1974). Of relevance to
this context is the finding that in the chicken oviduct, most of the high-affinity
micronutrient binding proteins produced for deposition in the egg white are in the
ligand-free apo-protein form (conalbumin, avidin and RCP). It has been hypothesised
that their primary physiological role is related to their high capacity to avidly sequester
these nutrients that may be released accidently during the development of the embryo
which otherwise is rendered highly vulnerable to microbial destruction. Conceivably
the uterine luminal TCP might also accomplish a similar function in terms of protective
surveillance of the sensitive early embryo. 
From the foregoing, it may be concluded that despite pronounced differences
between the rat and the chicken in terms of the patterns of their embryonic
development, the carrier-mediated thiamin delivery mechanism is conserved during the
evolutionary transition. Not only conformational and ligand-binding characteristics of
the TCP are retained, but also the hormonal specificity of induction and dual sites of
biosynthesis during the reproductive phase of the animals are preserved. In other
words, the entire synthetic apparatus including modulatory aspects governing its
function are conserved from the oviparous to viviparous species apparently to fulfil a
fundamental biological role, viz., a carrier-mediated micronutrient delivery mechanism
to  ensure  embryonic  development  and  hence  perpetuation  of  the  species.
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